Table 3 |
||||
|
Grading and Staging Data for PSA-Positive Cases |
||||
|
Age/Sex |
Nuclear Grade |
Tumor Size |
Lymph Node Status |
Immunohistochemistry |
|
|
||||
|
62 F |
I |
1.5 cm |
Negative (0/18) |
PSA+ (diffuse), PSAP-, AR-, ER-, PR- |
|
|
||||
|
75 F |
III |
2.5 cm |
Negative (0/11) |
PSA+ (focal), PSAP- AR+, ER+, PR+ |
|
|
||||
|
58 M |
III |
1.3 cm |
Positive (2/13) |
PSA+ (focal), PSAP-, AR+, ER+, PR+ |
|
|
||||
|
PSA - prostate specific antigen; PSAP - prostate specific acid phosphatase; AR - androgen receptor; ER - estrogen receptor; PR - progesterone receptor. |
||||
|
Kraus et al. Diagnostic Pathology 2010 5:63 doi:10.1186/1746-1596-5-63 |
||||
